Mdivi1 ameliorates mitochondrial dysfunction in non‐alcoholic steatohepatitis by inhibiting JNK/MFF signaling
Journal of Gastroenterology and Hepatology · 2023
DOI: 10.1111/jgh.16372 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2023. Verfasst von Ying Quan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Mitochondrial Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Natural Science Foundation of China, Science and Technology Planning Project of Guangdong Province, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Background and Aims Mitochondrial dysfunction plays a crucial role in the progression of non‐alcoholic steatohepatitis (NASH). Mitochondrial division inhibitor 1 (Mdivi1) is a potential inhibitor of dynamin‐related protein (Drp1) and mitochondrial fission. However, the therapeutic effect of Mdivi1 against NASH and its underlying molecular mechanisms remain unclear.
Methods
In this study, we established mouse models of NASH by inducing high‐fat/high‐cholesterol (HFHC) or methionine‐ and choline‐deficient (MCD) diets and treated the animals with 5 mg/kg/day Mdivi1 or placebo.
Results
Treatment with Mdivi1 significantly alleviated diet‐induced fatty liver phenotypes, including increased liver weight/body weight ratio, insulin resistance, hepatic lipid accumulation, steatohepatitis, and liver injury. Furthermore, Mdivi1 treatment suppressed HFHC or MCD diet‐induced changes in the expression of genes related to lipid metabolism and inflammatory cytokines. Additionally, Mdivi1 reduced macrophage infiltration in the injured liver and promoted polarization of macrophages towards the M1 phenotype. At the molecular level, Mdivi1 attenuated mitochondrial fission by reducing Drp1 activation and expression, thereby decreasing mitochondrial reactive oxygen species accumulation and mitochondrial DNA damage. Moreover, Mdivi1‐treated mice exhibited elevated levels of phosphorylated‐c‐Jun N‐terminal kinase (p‐JNK), mitochondrial fission factor (MFF), cleaved caspase 3 protein, and TUNEL‐positive cell expression in the liver, suggesting that Mdivi1 might ameliorate mitochondrial dysfunction and reduce hepatocyte apoptosis by inhibiting the JNK/MFF pathway.
Conclusion
Collectively, Mdivi1 protected against diet‐induced NASH by restoring mitochondrial homeostasis and function, potentially through its inhibitory effect on the JNK/MFF pathway. Consequently, further investigation of Mdivi1 as a promising drug for NASH treatment is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, Guangzhou, China.
- Department of Gastroenterology and Hepatology, Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
ORCID-Profile: Yongjian Zhou
Förderung
- Natural Science Foundation of China
- Science and Technology Planning Project of Guangdong Province
- Natural Science Foundation of Guangdong Province
- Science and Technology Projects in Guangzhou
- National Natural Science Foundation of China
Zitieren
APA
Quan, Y., Shou, D., Yang, S., Cheng, J., Li, Y., Huang, C., Chen, H., & Zhou, Y. (2023). Mdivi1 ameliorates mitochondrial dysfunction in non‐alcoholic steatohepatitis by inhibiting JNK/MFF signaling. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16372
Vancouver
Quan Y, Shou D, Yang S, Cheng J, Li Y, Huang C, et al. Mdivi1 ameliorates mitochondrial dysfunction in non‐alcoholic steatohepatitis by inhibiting JNK/MFF signaling. Journal of Gastroenterology and Hepatology. 2023. doi:10.1111/jgh.16372
BibTeX
@article{Quan2023,
author = {Quan, Ying and Shou, Diwen and Yang, Siqi and Cheng, Jiemin and Li, Yongqiang and Huang, Chen and Chen, Huiting and Zhou, Yongjian},
title = {Mdivi1 ameliorates mitochondrial dysfunction in non‐alcoholic steatohepatitis by inhibiting JNK/MFF signaling},
journal = {Journal of Gastroenterology and Hepatology},
year = {2023},
doi = {10.1111/jgh.16372}
}
EUVIMED